Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02262845 · ClinicalTrials.gov registry record
Short Term Pancreatic Stenting Registry
A clinical trial of Post-ERCP Acute Pancreatitis and Pancreatic Duct Stricture, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 246
- Enrollment target
- 7
- Study locations
NCT02262845 is a study of Post-ERCP Acute Pancreatitis and Pancreatic Duct Stricture that has completed, run by Boston Scientific Corporation. The registered enrollment target is 246 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT02262845, a study of Post-ERCP Acute Pancreatitis and Pancreatic Duct Stricture, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 246 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to document clinical utility and distribution of indications for short term pancreatic stenting, and stent type preference by indication at tertiary referral centers with expertise in pancreatic endotherapy.
Conditions Studied
Interventions
- DEVICE The Advanix™ Pancreatic Stent and NaviFlex RX Pancreatic Delivery System and Pushers
Study Locations (7)
Other
- Evangelisches Krankenhaus Dusseldorf - Düsseldorf
- Erasmus Medical Center - Rotterdam
Pennsylvania
- Temple University School of Medicine - Philadelphia
South Carolina
- Medical University of South Carolina - Charleston
Texas
- Methodist Dallas Medical Center - Dallas
Washington
- Virginia Mason Medical Center - Seattle
Hyderabad
- Asian Institute of Gastroenterology - Somājigūda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02262845
The ClinicalTrials.gov registry entry for NCT02262845 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Post-ERCP Acute Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which The Advanix™ Pancreatic Stent and NaviFlex RX Pancreatic Delivery System and Pushers is the first listed.
NCT02262845 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Other, Pennsylvania, South Carolina.
Frequently Asked Questions
What is clinical trial NCT02262845 about?
NCT02262845 is a clinical study titled "Short Term Pancreatic Stenting Registry". The purpose of this study is to document clinical utility and distribution of indications for short term pancreatic stenting, and stent type preference by indication at tertiary referral centers with expertise in pancreatic endotherapy.
What is the current status of trial NCT02262845?
This trial is currently completed. The enrollment target is 246 participants. The study started on 2015-02. Estimated completion is 2016-09.
What conditions does trial NCT02262845 study?
This clinical trial studies the following conditions: Post-ERCP Acute Pancreatitis, Pancreatic Duct Stricture, Pancreatic Duct Stones, Pancreatic Duct Leakage.
What interventions are being tested in trial NCT02262845?
The interventions under investigation include: The Advanix™ Pancreatic Stent and NaviFlex RX Pancreatic Delivery System and Pushers (DEVICE).
Who is sponsoring clinical trial NCT02262845?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02262845 being conducted?
This trial has 7 study locations across Pennsylvania, South Carolina, Texas, Washington, Hyderabad. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-ERCP Acute Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Post-ERCP Acute Pancreatitis
All registered trials for this condition
Pancreatic Duct Stricture
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.